Momecutan (Mometasone Furoate)

Mometasone furoate, the active ingredient in Momecutan, is a glucocorticoid presented as a topical formulation for topical use. It is employed to reduce inflammation and relieve symptoms in various dermatologic conditions such as psoriasis, eczema, atopic dermatitis and allergic skin reactions.

GNH USA supplies Momecutan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing consistent quality and regulatory‑approved batches for global dermatology markets. The company adheres to stringent Good Distribution Practice standards and offers reliable logistics, ensuring product integrity from manufacture to end‑user.

Momecutan (mometasone furoate) is a topical corticosteroid that targets inflammatory skin pathways.

- Psoriasis: reduces plaque formation, erythema and scaling. - Eczema: alleviates itching, redness and edema. - Atopic dermatitis: controls flare‑ups and skin irritation. - Allergic skin reactions: diminishes swelling and hypersensitivity symptoms.

Topical application of Momecutan may be associated with a range of local and systemic adverse reactions.

Common Side Effects: - Burning or stinging sensation at the application site. - Skin dryness or mild peeling. - Pruritus or mild irritation.

Serious or Rare Side Effects: - Skin atrophy or thinning with prolonged use. - Telangiectasia (visible small blood vessels) on treated areas. - Systemic adrenal suppression when used over large areas or with occlusion.

When using Momecutan, consider the following safety measures.

- Apply to limited skin areas: restrict use to affected sites to minimize systemic absorption. - Avoid use on broken or infected skin: may increase irritation or infection risk. - Limit duration of therapy: prolonged use can lead to skin atrophy. - Use pediatric caution: children may be more susceptible to systemic effects. - Do not combine with other potent topical steroids without medical advice. - Store at room temperature: keep in original container, protect from moisture and heat.

Momecutan can interact with other medicines; awareness of major and moderate interactions helps ensure safe use.

Major Interactions (Avoid): - Concurrent systemic corticosteroids: increased risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole) applied over extensive skin areas: may raise systemic exposure. - Occlusive dressings over large treated areas: enhances absorption, risk of HPA‑axis suppression.

Moderate Interactions (Monitor Closely): - Other immunosuppressive agents (e.g., tacrolimus): monitor for additive immunosuppression. - Concurrent antiviral or antifungal topicals: assess for local irritation. - Photosensitizing drugs: advise sun protection while using the steroid.